We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
4 Reasons to Invest in Cohen & Steers (CNS) Stock Right Now
Read MoreHide Full Article
Cohen & Steers’ (CNS - Free Report) strong fundamentals and solid growth prospects make it an attractive investment option. The stock has been witnessing upward estimate revisions off late, reflecting analysts’ optimism regarding its earnings growth potential.
Over the past 60 days, the company’s Zacks Consensus Estimate for 2018 earnings has been revised nearly 1% upward. Thus, the stock currently carries a Zacks Rank #2 (Buy).
Cohen & Steers’ price performance also seems impressive. The stock has gained 7.6% in the past year against the industry’s decline of 2.9%.
Mentioned below are some other aspects that make Cohen & Steers a solid pick right now.
Revenue Strength: Driven by improving AUM balance, Cohen & Steers’ revenues have increased at a CAGR of 6.2% over the last five years (2013-2017). Further, the top line is expected to grow 1.5% in 2018, higher than the industry average of 0.5%.
Earnings Growth: Cohen & Steers witnessed earnings growth of 6.4% in the last three-five years, higher than the industry average of 4.1%. This earnings momentum is likely to continue in the near term, as reflected by its projected earnings per share (EPS) growth rate of 19.3% for 2018 and 4.3% for 2019.
Further, the company’s long-term (three to five years) estimated EPS growth rate of 9.4% promises rewards for investors in the long run.
Strong Leverage: Cohen & Steers’ debt/equity ratio is 0.00, which indicates that the company uses no debt to finance its operations. On the other hand, the industry’s debt/equity ratio stands at 0.22. This shows that the company will be financially stable, even in adverse economic conditions.
Superior Return on Equity (ROE): Cohen & Steers’ ROE of 37.09% compares favorably with the industry’s average of 12.95%. This highlights the company’s commendable position over its peers.
Ameriprise Financial’s Zacks Consensus Estimate for current-year earnings has been revised 1.7% upward over the past 60 days. The company’s share price has increased 2% over the past year.
Lazard has witnessed an upward earnings estimate revision of 2.9% for the current year over the past 60 days. The stock has gained 10.1% in the past year.
SEI Investments’ Zacks Consensus Estimate for current-year earnings has been revised nearly 1% upward over the past 60 days. Additionally, the company’s shares have gained 6.4% in a year’s time.
5 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2018 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs. A bonus Zacks Special Report names this breakthrough and the 5 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains.
Image: Bigstock
4 Reasons to Invest in Cohen & Steers (CNS) Stock Right Now
Cohen & Steers’ (CNS - Free Report) strong fundamentals and solid growth prospects make it an attractive investment option. The stock has been witnessing upward estimate revisions off late, reflecting analysts’ optimism regarding its earnings growth potential.
Over the past 60 days, the company’s Zacks Consensus Estimate for 2018 earnings has been revised nearly 1% upward. Thus, the stock currently carries a Zacks Rank #2 (Buy).
Cohen & Steers’ price performance also seems impressive. The stock has gained 7.6% in the past year against the industry’s decline of 2.9%.
Mentioned below are some other aspects that make Cohen & Steers a solid pick right now.
Revenue Strength: Driven by improving AUM balance, Cohen & Steers’ revenues have increased at a CAGR of 6.2% over the last five years (2013-2017). Further, the top line is expected to grow 1.5% in 2018, higher than the industry average of 0.5%.
Earnings Growth: Cohen & Steers witnessed earnings growth of 6.4% in the last three-five years, higher than the industry average of 4.1%. This earnings momentum is likely to continue in the near term, as reflected by its projected earnings per share (EPS) growth rate of 19.3% for 2018 and 4.3% for 2019.
Further, the company’s long-term (three to five years) estimated EPS growth rate of 9.4% promises rewards for investors in the long run.
Strong Leverage: Cohen & Steers’ debt/equity ratio is 0.00, which indicates that the company uses no debt to finance its operations. On the other hand, the industry’s debt/equity ratio stands at 0.22. This shows that the company will be financially stable, even in adverse economic conditions.
Superior Return on Equity (ROE): Cohen & Steers’ ROE of 37.09% compares favorably with the industry’s average of 12.95%. This highlights the company’s commendable position over its peers.
Other Stocks to Consider
A few other top-ranked stocks in the same space are Ameriprise Financial, Inc. (AMP - Free Report) , Lazard Ltd (LAZ - Free Report) and SEI Investments Co. (SEIC - Free Report) . Each of these stocks has a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Ameriprise Financial’s Zacks Consensus Estimate for current-year earnings has been revised 1.7% upward over the past 60 days. The company’s share price has increased 2% over the past year.
Lazard has witnessed an upward earnings estimate revision of 2.9% for the current year over the past 60 days. The stock has gained 10.1% in the past year.
SEI Investments’ Zacks Consensus Estimate for current-year earnings has been revised nearly 1% upward over the past 60 days. Additionally, the company’s shares have gained 6.4% in a year’s time.
5 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2018 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs. A bonus Zacks Special Report names this breakthrough and the 5 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains.
Click to see them right now >>